Page 132 - Journal of Special Operations Medicine - Spring 2017
P. 132

to be a quick reference guide but is not stand alone:   •  If a continuous drip is selected, use only a ketamine
          you must also know the information in the rest of the   drip in most situations, augmented by push doses
          guideline.                                           of opioid and/or midazolam if needed. Multiple
                                                               drips are difficult to manage and are generally not
          Medications in the table are presented as either Give or     recommended.
          Consider.
          •  Give: Strongly recommended.                         Multiple drips should only be undertaken with as-
          •  Consider: Requires a complete assessment of patient   sistance from a telemedicine consultant with critical care
            condition, environment, risks, benefits, equipment,   experience. Multiple drips are most likely to be helpful
            and provider training.
                                                             in patients who remain difficult to sedate with ketamine
                                                             drip alone and can “smooth out” the sedation (i.e.,
          Step 1. Identify the clinical condition
                                                             fewer peaks and troughs of sedation with corresponding
                                                             deep sedation mixed with periods of acute agitation).
          •  Standard analgesia is for most patients. The therapies
            used  here  are  the  foundation  for  pain  management
            during PFC. Expertise in dosing oral transmucosal   •  Remember: IV fluid administration in any form
            fentanyl citrate (OTFC) and augmenting it with low-  is cumulative.
            dose ketamine IV or IO is a must.
          •  Difficult analgesia or sedation needed is for patients in
            whom standard analgesia does not achieve adequate   Regional Anesthesia (Appendix E)
            pain control without suppressing respiratory drive or
            causing hypotension, OR when mission requirements   Regional anesthesia (e.g., local anesthetic such as ropiva-
            necessitate sedating a patient to gain control over his/  caine or lidocaine injected adjacent to a large,  extremity
            her actions to achieve patient safety, quietness, or nec-  nerve bundle or on either side of a finger or toe) is a
            essary positioning.                              useful technique that can markedly reduce or eliminate
          •  Protected airway with mechanical ventilation is for   limb pain without risk of opioid or benzodiazepine side-
            patients who have a protected airway and are receiv-  effects of respiratory depression, sedation, and hypoten-
            ing mechanical ventilatory support or are receiving full   sion. There are, however, serious potential morbidities
            respiratory support via assisted ventilation (i.e., bag   (and mortality from proximal injections or injection di-
            valve).                                          rectly into blood vessels) that may occur.
          •  Shock present is for patients who have hypotension
            and shock.                                       For these reasons, this guideline has attempted to balance
                                                             the overall risks and potential benefits of this interven-
          Step 2. Read down the column to the row representing   tion by recommending optimal procedure technique (e.g.,
          your available resources and training.             use of ultrasound), a limited number of block sites, and
                                                             the safest medication and dose combination. It should
          Step 3. Provide analgesia/sedation medication accordingly.  be noted that even with optimal technique, the risk of
                                                             systemic toxicity (e.g., seizure or cardiac arrest) is not
          Step 4. Consider using the Richmond Agitation-Seda-  eliminated. Toxicity occurs either with direct injection
          tion Scale (RASS) score (Appendix F) as a method to   of anesthetic into the systemic blood circulation or by
          trend the patient’s sedation level.                absorption over the first 15–20 minutes after injection.
                                                             Close monitoring MUST be available during this time.
          For IV/IO drip medications:
                                                             Regional anesthesia should only be used by trained indi-
          •  Use normal saline to mix medication drips when pos-  viduals. There should be documentation of competency.
            sible, but other  crystalloids (e.g., lactated Ringer’s,   Three techniques exist:
            Plasmalyte, and so forth) may be used if normal saline
            is not available.                                •  Ultrasound-guidance: used to visualize targeted nerves,
          •  DO NOT mix more than one medication in the same   needle placement, and the spread of local anesthetic in
            bag of crystalloid because this practice has not been   real time.
            studied and may not  be safe. Mixing medications   •  Nerve stimulation: requires an assistant, a nerve stimu-
            together, even for a relatively short time, may cause   lator, specialized needles, and cannot be reliably  applied
            changes to the chemical structure of one or both med-  in cases of partial or complete amputations, given the
            ications and could lead to toxic compounds. There   inability to elicit motor response in severed muscles.
            is ongoing research to determine the safety of such   •  Blind or anatomical technique: should be reserved for
            practices.                                         distal nerve blocks only (i.e., fingers or toes).



          108                                     Journal of Special Operations Medicine  Volume 17, Edition 1/Spring 2017
   127   128   129   130   131   132   133   134   135   136   137